Related Experiment Video
Updated: Oct 15, 2025
11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
14.0K
Midterm Outcomes for Polytetrafluoroethylene Valved Conduits.
Qiqi Shi1, Yaping Shan1, Gang Chen1
1Department of Cardiothoracic Surgery, Children's Hospital of Fudan University, Shanghai, China.
The Annals of Thoracic Surgery
|October 31, 2021
Summary
A novel handsewn expanded polytetrafluoroethylene (ePTFE) valved conduit shows promising midterm results for right ventricular outflow tract reconstruction, with no reinterventions needed. This cardiac surgery innovation offers a viable option for patients requiring this complex procedure.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Medical Device Engineering
Background:
- Limited availability of commercial conduits for right ventricular outflow tract (RVOT) reconstruction in China.
- Development of a novel, simple, handsewn valved conduit using expanded polytetrafluoroethylene (ePTFE).
Purpose of the Study:
- To evaluate the midterm clinical and hemodynamic outcomes of a newly developed handsewn ePTFE valved conduit for RVOT reconstruction.
- To assess the safety and efficacy of this ePTFE conduit in a pediatric cardiac surgery population.
Main Methods:
- Retrospective study of 72 patients undergoing RVOT reconstruction with ePTFE valved conduits (January 2014 - June 2020).
- Midterm follow-up included echocardiography for all patients and cardiac MRI for those with repaired Tetralogy of Fallot.
- Analysis of patient demographics, conduit size, hemodynamic parameters, and adverse events.
Main Results:
- Median follow-up of 33 months with no early deaths and a 2.78% late mortality rate.
- Favorable valve function with trivial to mild pulmonary regurgitation in most patients (98.5%).
- Significant decrease in right ventricular end-diastolic volume index in Tetralogy of Fallot patients post-surgery (P < .001), with no need for reintervention or conduit replacement.
Conclusions:
- The handsewn ePTFE valved conduit demonstrates appreciable midterm hemodynamic outcomes.
- This novel conduit represents a potentially effective and accessible option for RVOT reconstruction.
- Further long-term follow-up studies are warranted to confirm these encouraging findings.
